Cardinal Health, a provider of products and services supporting the health-care industry, Wednesday announced organizational changes to align its manufacturing businesses and sharpen its focus on expanding the market for its products and services outside the United States.
David L. Schlotterbeck, 59, has assumed additional responsibility for Cardinal Health's Pharmaceutical Technologies and Services (PTS) and Medical Products Manufacturing (MPM) segments, in addition to his current responsibility for the Clinical Technologies and Services (CTS) segment. As chief executive officer of Pharmaceutical and Medical Products, Schlotterbeck will lead an organization of approximately 23,000 employees and $6 billion in revenues.
The company said PTS, MPM and CTS will remain separate financial reporting segments and separate internal organizations. However the new structure will foster a uniform approach to lean manufacturing and Six Sigma initiatives, and common processes for innovation, research and development, and sourcing.
Cardinal Health also announced that R. G. G. (Rudy) Mareel has joined the company as president of International. In this role, Mareel, 43, will report to Clark and will develop and implement the company's international strategy. He will also assume the responsibilities of John Parker, president of Cardinal Health Europe, who announced plans to retire earlier this year.